Get the tools used by (smart)² investors.

Watchlists Ideas Screener Data Explorer Charts Saved Work

Cash Return On Invested Capital (CROIC)

Join now and get access to the full platform

Search for company or ETF

0 results available. Select is focused ,type to refine list, press Down to open the menu,

163.63

Price

–

Fair Value

–

Upside

140.68 - 169.99

52-week range

Create Chart Create Model Add To Watchlist

Analysis

Fiscal Years

Trailing Twelve Months

Fiscal Halfs

Fiscal Quarters

Daily

Hide this widget

The following section summarizes insights on 's Cash Return On Invested Capital (CROIC):

Performance Summary

Johnson & Johnson's latest twelve months cash return on invested capital (croic) is 19.0%
Johnson & Johnson's cash return on invested capital (croic) for fiscal years ending January 2021 to 2024 averaged 18.3%.
Johnson & Johnson's operated at median cash return on invested capital (croic) of 19.0% from fiscal years ending January 2021 to 2024.
Looking back at the last 5 years, Johnson & Johnson's cash return on invested capital (croic) peaked in January 2021 at 21.5%.
Johnson & Johnson's cash return on invested capital (croic) hit its 5-year low in January 2023 of 15.2%.
Johnson & Johnson's cash return on invested capital (croic) decreased in 2021 (21.5%, -3.7%), 2022 (19.0%, -11.8%), and 2023 (15.2%, -19.9%) and increased in 2023 (16.8%, +10.9%) and 2024 (19.0%, +13.0%).

How does J&J's Cash Return On Invested Capital (CROIC) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Johnson & Johnson because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

J&J Cash Return On Invested Capital (CROIC) Benchmarks
Name	Ticker	Cash Return On Invested Capital (CROIC)
Talphera Inc	NASDAQGM:TLPH	-84.0%
NovaBay Pharmaceuticals Inc	NYSEAM:NBY	-76.6%
Vyne Therapeutics Inc	NASDAQCM:VYNE	-48.3%
Nutriband Inc	NASDAQCM:NTRB	-43.8%
Healthcare	SECTOR:HLTH.US	-23.6%
ANI Pharmaceuticals Inc	NASDAQGM:ANIP	5.3%
Viatris Inc	NASDAQGS:VTRS	5.5%
Eli Lilly and Company	NYSE:LLY	8.7%
Johnson & Johnson	NYSE:JNJ	19.0%
Bristol-Myers Squibb Company	NYSE:BMY	20.1%
Novartis AG ADR	NYSE:NVS	21.9%
Merck & Company Inc	NYSE:MRK	22.8%

Metric Usage: Cash Return on Invested Capital (CROIC)

Hide this widget

croic

Slug

number

Datatype

text

Format

current

Default Period

FY, LTM

Periods Supported

Free

Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Cash Return On Invested Capital (CROIC) in the efficiency category include:

Income Tax Expense Margin - A ratio that measures the GAAP taxes applicable to the earnings after all expenses have been deducted by the business as a percent of revenue.
EBITDA Margin CAGR (10y) - Ten-year compound annual growth rate in EBITDA margin.
EBITDA Margin CAGR (7y) - Seven-year compound annual growth rate in EBITDA margin.
Avg Return on Common Equity Growth (2y) - Growth in two-year quarterly average return on common equity.

View Full List

Search for metric or datapoint

Cash Return on Invested Capital (CROIC)

A ratio that measures the amount of free cash flow a firm generates on each dollar of capital invested (debt + equity).

Definition of Cash Return On Invested Capital (CROIC)

Hide this widget

A ratio that measures the amount of free cash flow a firm generates on each dollar of capital invested (debt + equity).

Sector Benchmark Analysis

Sector

Industry Group

Industry

Hide this widget

The chart above depicts the distribution of cash return on invested capital (croic) for companies operating in the Healthcare sector in the Developed economic region. Over 2,450 companies were considered in this analysis, and 2,357 had meaningful values. The average cash return on invested capital (croic) of companies in the sector is -31.6% with a standard deviation of 76.4%.

Johnson & Johnson's Cash Return On Invested Capital (CROIC) of 19.0% ranks in the 89.9% percentile for the sector. The following table provides additional summary stats:

Cash Return On Invested Capital (CROIC) In The Healthcare Sector
Economic Risk Region	Developed
Total Constituents	2,455
Included Constituents	2,357
Min	-437.8%
Max	324.9%
Median	-12.4%
Mean	-31.6%
Standard Deviation	76.4%

You can find companies with similar cash return on invested capital (croic) using this stock screener.